Below are 10 different webinars which can enrich your life and business. Click on the links to quickly scroll to that webinar.
Technology licensing negotiations are an important and often daunting prospect for inventors and entrepreneurs. Understanding university needs and objectives in advance, doing the homework on your business opportunity, and thinking ahead to future financings and company transactions will help you set accurate expectations and reach agreement more easily.
Sick’s deep experience in biotechnology and life sciences stems from an 18-year career at Invitrogen Corporation & Life Technologies, now part of Thermo Fischer Scientific. Today, he advises start-up and early-stage biotechnology companies on operations management and deal expertise. Key topics include:
Structure the company correctly so you don’t have to start over and do it again. Tippie's background is in operations and venture financing, with a specific focus on life sciences. He has been instrumental in facilitating acquisitions, public offerings, and venture funding with numerous early-stage companies. Key topics include:
Technology and market development are essential work for science startups. But just as important is company financial and legal structure. Early mistakes or poor choices can be costly or fatal later. There is a lot to decide: corporate form (LLC, C-Corp, S-Corp), equity ownership and vesting, compensation arrangements, employee and contractor agreements, IP/invention assignments and more. Veteran startup and venture fund attorney and CPA Jon Summers will help you start off in the right direction.
Blackstone has helped grow companies for over 30 years, working with organizations ranging from Fortune 500 corporations to entrepreneurial startups. He is a master marketer whose work has gained national media attention, such as on 60 Minutes. Key topics are:
What is the purpose of detailed financial statements when your company is pre-revenue, and everyone knows the revenue projections are wrong? Veteran angel investor and fund manager Susan Preston will show you how to use the three basic financial documents (balance sheet, income, and cash flow statements) to show investors that you have done your homework and are ready for serious consideration.
The National Science Foundation (NSF) invested about $200 million this year into hundreds of startups and small businesses founded around innovative, high-risk technologies. These firms are working on the next generation of game-changing innovations in fields from synthetic biology to the internet of things to autonomous vehicles to bio-based materials. For most of these firms, NSF support represents the first outside funding into the company, and over three-quarters of them have five or fewer employees.
Prior to founding ONAMI in 2003, Skip established an innovation consulting practice in 2001. Before that, he was a senior executive and R&D director at Hewlett-Packard’s Corvallis facility. Key topics will include:
What happens behind the scenes when you contact an early-stage investor group (e.g. angel or VC firm) seeking your first round of funding? Investors are very careful with their investors and limited partner’s money. Assuming you have caught their interest, you should anticipate a lot of questions, document requests, independent market-technology-IP evaluation, and reference checks on key personnel.
Returning presenter Eric Boothe of Elevate Capital will present the ideal route to raising a round, including what it means to "soft circle" and "hard circle" money, and how to solicit and lock-in a lead investor. This session includes extra Q&A on this challenging part of launching a company.